LegalZoom.com heads into its Q1 2026 earnings print — due after the bell on May 7 — with short sellers cutting exposure at a notable pace, the stock up 15% over the past month, yet still trading well below where analysts have set their targets.
Short interest has been the defining story of the past six weeks. It peaked near 13.9% of the free float in late March, and has shed almost a quarter of that position since — falling to 10.6% by May 5. The pace of unwinding has accelerated into the print. Shorts are down roughly 1.5% week-on-week and 17% over the past month, with share count dropping from around 14.9 million shorted at the end of March to 12.4 million now. That is a meaningful cover, not a rounding error. Borrow conditions offer little reason to stay short: cost to borrow is a negligible 0.48% annualised, and borrow availability remains loose — the lending market is not offering any friction to discourage the exit.
Options positioning adds little urgency to the story. The put/call ratio is essentially flat at 0.61, right in line with its 20-day average of 0.61 — a near-zero z-score of 0.02. The 52-week low on the PCR was 0.04, the high just 0.66, so the current reading is close to the defensive end of this stock's historical range, but there is no fresh spike in downside protection ahead of the release. The ORTEX short score of 51.6 is middling — not elevated enough to signal acute crowding — and it has been drifting slightly lower since a brief push toward 52.5 in late April.
The Street's take on LZ has been one of steady attrition. In the most recent moves ahead of this article's writing, Barclays downgraded to Underweight in early March and cut the target from $9 to $6 — close to where the stock is trading now. UBS lowered its Neutral target from $12 to $8 around the February earnings release, and JP Morgan trimmed from $14 to $11 while holding Overweight. The consensus is a hold, with the mean target around $8.71, implying roughly 30% upside from current levels — though that figure is anchored to the February/March round of cuts and should be taken in context of a stock that was above $10 six months ago. Factor scores lean modestly positive: the 90-day EPS momentum rank is 80th percentile, and the 12-month forward EPS growth rank is at the 90th percentile. The EV/EBIT rank sits at just the 2nd percentile, however — a sign that on some valuation measures the stock screens as expensive relative to its earnings base.
Institutional ownership adds an interesting backdrop. BlackRock added more than 7 million shares as of the April 30 report, lifting its stake to over 10% of the company. Goldman Sachs Asset Management added around 2.3 million shares through March 31. Those are large moves relative to typical quarterly drift, and they arrived while the stock was under pressure. Francisco Partners and TCMI together hold around 26% of shares between them, with neither showing a change in the latest filings — a stable core. On the insider side, the picture is less constructive: the CFO, CEO, Chief Legal Officer, and Chief Accounting Officer all sold in February at prices around $6.87–$6.96. Net insider selling totalled around $1.49 million over the 90 days through February 26 — modest in absolute dollar terms but notable given that the entire C-suite moved together.
The earnings history is worth noting plainly. The February 2026 Q4 print saw the stock fall 11.6% the next day and recover to near-flat by the end of the week. The prior print moved it down 5.9% on the day. Two negative day-one reactions in a row. Bull-case arguments centre on rising business formation trends and strong demand for small-business legal services. The bear case points to a 29% year-on-year decline in website traffic — the core funnel for the business. That data is somewhat dated (as of late 2025), but the trend was deteriorating at the time it was compiled.
The key tension to watch on May 7 is whether traffic erosion has stabilised or whether it is feeding through to subscription metrics and revenue. Short sellers have already moved toward the exit, and institutional buyers have been stepping in — whether that repositioning is vindicated will depend entirely on what management says about the forward trajectory of formations activity.
See the live data behind this article on ORTEX.
Open LZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
